BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 27567555)

  • 1. FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
    Groheux D; Quere G; Blanc E; Lemarignier C; Vercellino L; de Margerie-Mellon C; Merlet P; Querellou S
    Diagn Interv Imaging; 2016 Oct; 97(10):1003-1017. PubMed ID: 27567555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
    Divisi D; Barone M; Zaccagna G; Crisci R
    Ann Med; 2017 Nov; 49(7):626-635. PubMed ID: 28590774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
    Spadafora M; Evangelista L; Gridelli C; Cuocolo A
    Eur J Radiol; 2017 May; 90():188-191. PubMed ID: 28583632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
    Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
    Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
    Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
    Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.
    Madsen PH; Holdgaard PC; Christensen JB; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2084-97. PubMed ID: 27164899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
    Chen S; Li X; Chen M; Yin Y; Li N; Li Y
    Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
    Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
    Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of
    Delgado Bolton RC; Calapaquí-Terán AK; Giammarile F; Rubello D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):229-233. PubMed ID: 31202725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging in lung cancer: positron emission tomography scan.
    Vansteenkiste JF
    Eur Respir J Suppl; 2002 Feb; 35():49s-60s. PubMed ID: 12064681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer.
    Usmanij EA; de Geus-Oei LF; Bussink J; Oyen WJ
    Curr Opin Pulm Med; 2015 Jul; 21(4):314-21. PubMed ID: 25978629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental
    Spadafora M; Pace L; Mansi L
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):1-4. PubMed ID: 27695909
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
    Şahin E; Kara A; Elboğa U
    Radiol Med; 2016 Dec; 121(12):944-949. PubMed ID: 27567614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?
    Juergens KU; Weckesser M; Stegger L; Franzius C; Beetz M; Schober O; Heindel W; Wormanns D
    Eur Radiol; 2006 May; 16(5):1131-7. PubMed ID: 16450084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-related
    Spadafora M; Pace L; Evangelista L; Mansi L; Del Prete F; Saladini G; Miletto P; Fanti S; Del Vecchio S; Guerra L; Pepe G; Peluso G; Nicolai E; Storto G; Ferdeghini M; Giordano A; Farsad M; Schillaci O; Gridelli C; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1908-1914. PubMed ID: 29730697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.